Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preclinical studies with trimetrexate: a review of conclusions and unanswered questions.

× No keyword cloud information.

6 in total

1. Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma.

Authors: F V Fossella; R J Winn; P Y Holoye; B Hallinan; M N Raber; K Hoelzer; J A Young; J Readling; B Bowers; W K Hong
Journal: Invest New Drugs Date: 1992-11 Impact factor: 3.850

2. Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas. A phase II study of the Northern California Oncology Group.

Authors: R W Carlson; J H Doroshow; O O Odujinrin; M S Flam; M Malec; K R Lamborn
Journal: Invest New Drugs Date: 1990-11 Impact factor: 3.850

Review 3. Clinical pharmacokinetics and pharmacology of trimetrexate.

Authors: J L Marshall; R J DeLap
Journal: Clin Pharmacokinet Date: 1994-03 Impact factor: 6.447

4. A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.

Authors: L B Grochow; D A Noe; D S Ettinger; R C Donehower
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

5. Trimetrexate in advanced renal cell carcinoma. An ECOG phase II trial.

Authors: R S Witte; P Elson; G T Bryan; D L Trump
Journal: Invest New Drugs Date: 1992-04 Impact factor: 3.850

6. Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer.

Authors: Agustin A Garcia; Lawrence Leichman; Joaquina Baranda; Lalita Pandit; Heinz-Josef Lenz; Cynthia G Leichman
Journal: Int J Gastrointest Cancer Date: 2003

6 in total